A cost-effectiveness analysis of infrainguinal bypass in the absence of great saphenous vein conduit

Journal of Vascular Surgery

Volumn 57, Issue 6, 2013, Pages 1466-1470

  Barshes, Neal R ^a   Ozaki, C Keith ^b   Kougias, Panos ^a   Belkin, Michael ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ALLOGRAFT; AMPUTATION; ARTICLE; AUTOLOGOUS ALTERNATIVE VEIN; BLOOD VESSEL GRAFT; BYPASS SURGERY; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; ENDOVASCULAR SURGERY; HEALTH CARE COST; HUMAN; INFRAINGUINAL BYPASS; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAPHENOUS VEIN; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VASCULAR SURGERY; WOUND CARE; AGED; BLOOD VESSEL PROSTHESIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; ECONOMICS; FEMALE; INGUINAL REGION; ISCHEMIA; LEG; MALE; METHODOLOGY; PROBABILITY; VASCULARIZATION;

AGED; BLOOD VESSEL PROSTHESIS; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; FEMALE; GROIN; HUMANS; ISCHEMIA; LEG; MALE; MARKOV CHAINS; POLYTETRAFLUOROETHYLENE; SAPHENOUS VEIN; VASCULAR SURGICAL PROCEDURES;

MLCS; MLOWN;

EID: 84880841560     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.11.115     Document Type: Article

References (23)

1. Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 2011;42(suppl 2):S43-59.
2. Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007;46:1180-90; discussion: 1190.
3. Arvela E, Söderström M, Albäck A, Aho PS, Venermo M, Lepäntalo M. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg 2010;52:616-23.
4. Faries PL, Logerfo FW, Arora S, Hook S, Pulling MC, Akbari CM, et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080-90.
5. Shandall AA, Leather RP, Corson JD, Kupinski AM, Shah DM. Use of the short saphenous vein in situ for popliteal-to-distal artery bypass. Am J Surg 1987;154:240-4.
6. Neville RF, Tempesta B, Sidway AN. Tibial bypass for limb salvage using polytetrafluoroethylene and a distal vein patch. J Vasc Surg 2001;33:266-71; discussion: 271-2.
7. Lauterbach SR, Torres GA, Andros G, Oblath RW. Infragenicular polytetrafluoroethylene bypass with distal vein cuffs for limb salvage: a contemporary series. Arch Surg 2005;140:487-93; discussion: 493-4.
8. Randon C, Jacobs B, De Ryck F, Beele H, Vermassen F. Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vasc Surg 2010;51:869-77.
9. Albertini JN, Barral X, Branchereau A, Favre JP, Guidicelli H, Magne JL, et al. Long-term results of arterial allograft below-knee bypass grafts for limb salvage: a retrospective multicenter study. J Vasc Surg 2000;31:426-35.
10. Clagett GP. Does vascular surgery cost too much? J Vasc Surg 2009;50:1211-8.
11. Taylor SM. Current status of heroic limb salvage for critical limb ischemia. Am Surg 2008;74:275-84.
12. Bradbury AW. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective. J Vasc Surg 2010;51:1-4S.
13. Barshes NR, Chambers JD, Cohen J, Belkin M; Model To Optimize Healthcare Value in Ischemic Extremities 1 (MOVIE) Study Collaborators. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg 2012;56:1015-1024.e1.
14. Barshes NR, Belkin M; MOVIE Study Collaborators. A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg 2011;213:552-566.e5.
15. Albers M, Romiti M, Brochado-Neto FC, Pereira CA. Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg 2005;42:449-55.
16. Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CAB. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003;37:1263-9.
17. Albers M, Romiti M, Pereira CA, Antonini M, Wulkan M. Metaanalysis of allograft bypass grafting to infrapopliteal arteries. Eur J Vasc Endovasc Surg 2004;28:462-72.
18. Barshes NR, Chambers JD, Cantor SB, Cohen J, Belkin M. A primer on cost-effectiveness analyses for vascular surgeons. J Vasc Surg 2012;55:1794-800.
19. NHS National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. Published June 2008. Available at: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdated June2008.pdf. Accessed September 20, 2012.
20. Gold M, Siegel J, Russell L, Weinstein M. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
21. Slim H, Tiwari A, Ritter JC, Rashid H. Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia. J Vasc Surg 2011;53:421-5.
22. Patient Protection and Affordable Care Act. PL 111-148. 3-23-2010.
23. Neumann PJ, Weinstein MC. Legislating against use of costeffectiveness information. N Engl J Med 2010;363:1495-7.